Acer Therapeutics Inc. (ACER) Stock Analysis
DELISTED 2023
What happened to Acer Therapeutics Inc. (ACER) stock?
Acer Therapeutics Inc. (ACER) no longer trades on public markets. It was delisted in November 2023. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- November 2023
- Last recorded price (historical):
- $0.6601 (last quote on record before the November 2023 delisting; historical, not a current quote)
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Acer Therapeutics Inc. (ACER). Acer Therapeutics Inc. is a pharmaceutical company focused on acquiring, developing, and commercializing therapies for serious rare and life-threatening diseases. Their pipeline includes clinical-stage candidates targeting vascular Ehlers-Danlos Syndrome, urea cycle disorders, and infectious diseases.
Last analyzed: Mar 16, 2026Acer Therapeutics Inc. (ACER) Healthcare & Pipeline Overview
More about this archive record
Can I still buy ACER shares?
No. ACER stopped trading on public markets in November 2023, so the shares are not available through a broker. Anything you see quoted for ACER elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before ACER stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Acer Therapeutics Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.